|
Quotes & Info
|
| MSLP > SEC Filings for MSLP > Form 8-K on 6-Jul-2012 | All Recent SEC Filings |
6-Jul-2012
Change in Directors or Principal Officers, Other Events, Financial Statements an
On July 3, 2012, MusclePharm Corporation (the "Company") appointed Lewis Gary Davis, as its Chief Financial Officer. In this capacity he is the Company's principal financial and accounting officer. Mr. Davis succeeded Larry Meer, who now serves as the Company's Treasurer.
From January, 2010 to prior to joining the company, Mr. Davis, age 58, worked as a certified public accountant for various clients, specializing in mergers and acquisitions. From November, 2004 to January, 2010, Mr. Davis served as executive vice president and chief financial officer of Bodybuilding.com, a sports, fitness and nutritional supplement on-line retail store. He previously was vice president and chief financial officer of US Ecology Corporation. Davis earned a Bachelor's Degree in Accounting from Boise State University and is near completion of a Master's Degree in Finance from Rochester Institute of Technology. He is a licensed certified public accountant.
Mr. Davis will be paid an annual gross salary starting at $130,000, receive a cash bonus of $30,000 for the remainder of 2012 in the event of satisfactory performance, and he will participate in the Company's standard employee benefit plans.
On July 3, 2012, the Company issued a press release announcing the appointment of Lewis Gary Davis as the Chief Financial Officer of the Company. The text of the press release is included as Exhibit 99.1 to this Form 8-K.
The information disclosed under this Item 8.01, including Exhibit 99.1 hereto, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Exchange Act and shall not be deemed incorporated by reference into any filing made under the Securities Act, except as expressly set forth by specific reference in such filing.
(d) Exhibits
The Exhibits listed below are furnished as Exhibits to this Current Report on Form 8-K.
Exhibit No. Description
99.1 Press release issued July 3, 2012
|
|